PD Dr. Gabriele Weitz-Schmidt, AlloCyte Pharmaceuticals AG, Basel
Development of a new generation of integrin targeting drugs
Start Date
17.05.2017 - 17:00
Event End
17.05.2017 - 18:00
Location
Universität Basel, Pharmazentrum
Development of a new generation of integrin targeting drugs